Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects

Thyroid cancer (TC) is the most common endocrine malignancy. TC is classified as differentiated TC (DTC), which includes papillary and follicular subtypes and Hürthle cell variants, medullary TC (MTC), anaplastic TC (ATC), and poorly differentiated TC (PDTC). The standard of care in DTC consists of...

ver descrição completa

Detalhes bibliográficos
Principais autores: Puliafito, Ivana, Esposito, Francesca, Prestifilippo, Angela, Marchisotta, Stefania, Sciacca, Dorotea, Vitale, Maria Paola, Giuffrida, Dario
Formato: Online Atigo Texto
Idioma:English
Publicado em: Frontiers Media S.A. 2022
Assuntos:
Endocrinology
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304687/
https://www.ncbi.nlm.nih.gov/pubmed/35872981
http://dx.doi.org/10.3389/fendo.2022.860671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304687/
https://www.ncbi.nlm.nih.gov/pubmed/35872981
http://dx.doi.org/10.3389/fendo.2022.860671

Registros relacionados